We are live on
!
Find out more
VPC
Vestal Point Capital Portfolio holdings
AUM
$3.58B
1-Year Est. Return
190.75%
This Fund
S&P 500
1 Year Est. Return
+190.75%
AUM
$3.58B
AUM Growth
+$851M
(+31%)
Holding
113
Top Buys
| 1 | +$210M | |
| 2 | +$166M | |
| 3 | +$118M | |
| 4 |
Arrowhead Research
ARWR
|
+$87M |
| 5 |
Immunocore
IMCR
|
+$70.6M |
Top Sells
| 1 | +$191M | |
| 2 | +$144M | |
| 3 | +$84.6M | |
| 4 |
Merck
MRK
|
+$81.6M |
| 5 |
Tyra Biosciences
TYRA
|
+$76.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Structure Therapeutics
GPCR
$3.05B
| – | – |
-35,000
|
|
||
102
Jazz Pharmaceuticals
JAZZ
$14.5B
| – | – |
-290,000
|
|
||
103
Lantheus
LNTH
$6.8B
| – | – |
-360,000
|
|
||
104
Mirum Pharmaceuticals
MIRM
$6.06B
| – | – |
-66,000
|
|
||
|
DFTX
105
Definium Therapeutics
DFTX
$2.7B
| – | – |
-637,000
|
|
||
|
106
Merck
MRK
$294B
| – | – |
-775,000
|
|
||
107
Penumbra
PEN
$12.5B
| – | – |
-50,000
|
|
||
108
Invesco QQQ Trust
QQQ
$479B
| – | – |
0
|
|
||
109
Rezolute
RZLT
$385M
| – | – |
-1,686,000
|
|
||
110
Sutro Biopharma
STRO
$477M
| – | – |
-243,000
|
|
||
111
Zymeworks
ZYME
$1.68B
| – | – |
-865,000
|
|
||
|
LENZ
112
LENZ Therapeutics
LENZ
$212M
| – | – |
-275,000
|
|
||
|
UPB
113
Upstream Bio Inc
UPB
$332M
| – | – |
-720,000
|
|